Table 7.
Regression analysis for predictors of COVID-19 severity in asthmatic children
| Predictor | Odds ratio | 95% CI | P-value | |
|---|---|---|---|---|
|
| ||||
| Lower bound | Upper bound | |||
| Male sex | 1.60 | 0.29 | 8.86 | 0.590 |
| Age (yr) | 1.16 | 0.88 | 1.53 | 0.298 |
| Duration of asthma (yr) | 1.24 | 0.87 | 1.76 | 0.227 |
| Daily low dose ICS or daily low dose ICS-formetrol | 2.00 | 0.35 | 11.44 | 0.436 |
| Daily medium dose ICS | 2.00 | 0.13 | 30.16 | 0.617 |
| Intake of LTRA | 2.41 | 0.46 | 12.72 | 0.301 |
| Oral bronchodilators | 1.75 | 0.34 | 8.98 | 0.503 |
| Oral corticosteroids | 0.49 | 0.05 | 4.94 | 0.542 |
| Moderate asthma | 0.25 | 0.03 | 2.18 | 0.210 |
| Severe asthma | 4.50 | 0.25 | 80.57 | 0.307 |
| Moderate/Severe asthma | 0.47 | 0.06 | 3.54 | 0.466 |
| Uncontrolled/Partly controlled asthma | 4.33 | 0.71 | 26.53 | 0.113 |
LTRA: leukotriene receptor antagonists, ICS: inhaled corticosteroid.